Haemonetics Corporation (HAE) News
Filter HAE News Items
HAE News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HAE News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest HAE News From Around the Web
Below are the latest news stories about HAEMONETICS CORP that investors may wish to consider to help them evaluate HAE as an investment opportunity.
WBA Q1 Earnings and Revenues Beat Estimates, Stock Up in Pre-MarketWalgreens delivers better-than-expected earnings and revenues in the first quarter of fiscal 2025. |
Tandem Diabetes Forges New R&D Agreement With UVA: Stock to Gain?TNDM enters a multi-year research collaboration with the UVA Center for Diabetes Technology for the development of AID systems. |
Haemonetics Sets Date for Publishing Third Quarter Fiscal Year 2025 Results: February 6, 2025Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish third quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, February 6, 2025. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on February 6, 2025. |
Why Haemonetics (HAE) is a Top Value Stock for the Long-TermThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. |
Should Exact Sciences Stock Stay in Your Portfolio Right Now?EXAS' solid focus on expanding its lead Cologuard test and advancing new solutions bodes well for investors. |
ILMN Stock Set to Gain From Latest Updates to the NovaSeq X SeriesIllumina advances NovaSeq X Series with a software upgrade and the new 25B 100-cycle and 200-cycle kits. |
Should National Vision Stock Be in Your Portfolio Right Now?Investors are optimistic about EYE stock, courtesy of its share gain in the Owned and Host segments. |
Veracyte Gains 44% in a Year: What's Driving the Stock?VCYT is gaining shares due to the strength of its Afirma and Decipher tests. |
Haemonetics to Present at 43rd Annual J.P. Morgan Healthcare ConferenceHaemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 14, 2025 at 5:15 pm Pacific Time. |
HAE vs. ABT: Which Stock Is the Better Value Option?HAE vs. ABT: Which Stock Is the Better Value Option? |